EPISODE · Sep 26, 2018 · 20 MIN
Type 2 Diabetes Treatment - Part 6 - SGLT2 Inhibitors
from Hospital and Internal Medicine Podcast · host Gil Porat, M.D., FACP, CPT
Sodium-Glucose Transporter 2 Inhibitors decrease glucose re-absorbtion. The diuretic effect, weight loss, DKA, cardiac outcomes, blood pressure, genital infections and a whole bunch of other information is discussed. SGLT2s include Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertagliflozin (Steglatro), with more to be released in the future.
NOW PLAYING
Type 2 Diabetes Treatment - Part 6 - SGLT2 Inhibitors
No transcript for this episode yet
Similar Episodes
No similar episodes found.